CRH downgraded to Hold from Buy at Stifel

Stifel downgraded CRH to Hold from Buy with a price target of $82, up from $80. The firm says that after years of CRH being one of its most preferred names, it sees limited upside for now. The stock has re-rated post the U.S. relisting, while Stifel now sees significant catch-up potential amongst CRH’s European peers, the analyst tells investors in a research note. The firm says the company screens less well verses its preferences for the sector.